1-Cyclopropyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine

Catalog No.: 
ACCIRV459
CAS No.: 
1235528-19-4
Molecular Formula: 
C9H13N3
Molecular Weight: 
163.22
1-Cyclopropyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$186.00InquiryInquiry
100mg97%$269.00InquiryInquiry
250mg97%$378.00InquiryInquiry
1g97%$782.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Cyclopropyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
IUPAC Name1-cyclopropyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
MDL No.MFCD19982329
Molecular FormulaC9H13N3
Molecular Weight163.22
SMILESC1(N=CN2C3CC3)=C2CCNC1
InChI KeyIJAJWDVNQRQBJG-UHFFFAOYSA-N
Synonym1-Cyclopropyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine;1H-Imidazo[4,5-c]pyridine, 1-cyclopropyl-4,5,6,7-tetrahydro-;1-Cyclopropyl-1H,4H,5H,6H,7H-imidazo[4,5-c]pyridine
CAS No.1235528-19-4

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCIRV459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCIRV459 route product structure diagram
    ACCIRV4591235528-19-4
Inquiry

2. ACCIRV459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCIRV459 route product structure diagram
    ACCIRV4591235528-19-4
Inquiry

3. ACCIRV459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCIRV459 route product structure diagram
    ACCIRV4591235528-19-4
Inquiry

Comments (0)